Culture

FDA Freezes COVID-Flu Combo Vaccine Trial Over Safety Concern 

October 22, 2024

Maker Novavax reported a recipient of the combination vaccine experienced symptoms of nerve cell damage. Novavax Shares Slump After 2Q Revenue Misses Estimate The U.S. Food and Drug Administration has put a trial of Novavax’s COVID-influenza and its standalone flu […]